Tofacitinib for the Treatment of Alopecia Areata and Its Variants

Trial Profile

Tofacitinib for the Treatment of Alopecia Areata and Its Variants

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs Tofacitinib (Primary)
  • Indications Alopecia areata
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 26 Apr 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017.
    • 08 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top